OOIR: Observatory of International Research

Papers

(The median citation count of Human Gene Therapy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Intra-Articular Delivery of an AAV-Anti-TNF-α Vector Alleviates the Progress of Arthritis in a RA Mouse Model	74
PASTE, Don't Cut: Genome Editing Tool Looks Beyond CRISPR and Prime	74
Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future	73
First Positive Clinical Data for In Vivo Genome Editing in Humans Opens “New Era of Medicine”	72
Isolating Natural Adeno-Associated Viruses from Primate Tissues with a High-Fidelity Polymerase	50
Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid	49
Gene Therapy and the Use of Animal Models: Why Mice Alone Are Not Sufficient	47
Bluebird Bio Chief Financial Officer Resigns as Company Raises “Going Concern” Doubts	44
Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling	42
Strategies to Attenuate Myocardial Infarction and No-Reflow Through Preservation of Vascular Integrity by Pigment Epithelium-Derived Factor	41
Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type II	37
Long-Term Follow-Up of Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy	36
Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell Disease	36
Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies	36
Efficacious Androgen Hormone Administration in Combination with Adeno-Associated Virus Vector-Mediated Gene Therapy in Female Mice with Pompe Disease	35
Ex Vivo Gene Therapy in Organ Transplantation: Considerations and Clinical Translation	33
Ocular Inflammation with Anti-Vascular Endothelial Growth Factor Treatments	32
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases	31
Gene Therapy in Global Health: Meeting the Needs of Chinese Patients with Beta-Thalassemia	30
A Cautiously Optimistic Outlook of a Designer Therapy for 1% of Duchenne Muscular Dystrophy Patients	30
Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat Model	29
Adeno-Associated Virus-Mediated Interleukin-12 Gene Expression Alleviates Lung Inflammation and Type 2 T-Helper-Responses in Ovalbumin-Sensitized Asthmatic Mice	28
pNaSS-Grafted PCL Film-Guided rAAV TGF-β Gene Therapy Activates the Chondrogenic Activities in Human Bone Marrow Aspirates	28
Advancing Precision Medicine with Gene and Cell Therapy in Malaysia: Ethical, Legal, and Social Implications	27
Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis	27

Suppression of CNS APOE4 Expression by miRNAs Delivered by the S2 AAVrh.10 Capsid-Modified AAV Vector	26
Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases	26
Global Rare Disease Research Symposium & The Second China Rare Disease Research and Translational Medicine Annual ConferenceShanghai, ChinaMay 23-25, 2025	25
Meta-Analysis and Optimization of the In Vitro Immortalization Assay for Safety Assessment of Retroviral Vectors in Gene Therapy	25
ESGCT 2021	24
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature	24
Immune Responses to Adeno-Associated Virus-Mediated CRISPR Therapy	22
Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell	22
Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders	22
Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop	22
Characterizing Complex Populations of Endogenous Adeno-Associated Viruses by Single-Genome Amplification	22
Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis	21
Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for Sensitive Analysis of Residual Protein Tat Bh1–101 in Lentiviral Vectors for Gene Therapy	21
rAAV Production and Titration at the Microscale for High-Throughput Screening	21
Correction to: An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature, by Ramirez et al. Hum Gene Ther	20
Lived Experience with Gene Therapy	20
Gene Therapy for Huntington's Disease: The Future Is in Gene Editing	19
uniQure, CSL Behring Launch $2B Hemophilia B Partnership	19
Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword	19
Primum Non Nocere: Should Gene Therapy Be Used to Prevent Potentially Fatal Disease but Enable Potentially Destructive Behavior?	19
Gene Therapy, the Immune System, and Vaccine Development: An Interview with Hildegund Ertl	19
The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular Dystrophy	18
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus Erythematosus	17
Modulation of AAV9 Galactose Binding Yields Novel Gene Therapy Vectors and Predicts Cross-Species Differences in Glycan Avidity	17
Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver	17
CRISPR/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem Cells	17
Quantitation of Residual Host Cell DNA in Recombinant Adeno-Associated Virus Using Droplet Digital Polymerase Chain Reaction	17
An Overview of the Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy	16
SP-101, A Novel Adeno-Associated Virus Gene Therapy for the Treatment of Cystic Fibrosis, Mediates Functional Correction of Primary Human Airway Epithelia From Donors with Cystic Fibrosis	16
AAV1-Mediated shRNA Knockdown of SASH1 in Rat Bronchus Attenuates Hypoxia-Induced Pulmonary Artery Remodeling	16
Patient Dies in Beam Trial of Sickle Cell Disease Candidate; Company Cites Conditioning	15
A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response	15
Adeno-Associated Virus-Mediated Gene Transfer of Inducible Nitric Oxide Synthase to an Animal Model of Pulmonary Hypertension	15
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Human Gene Therapy	15
Interview with Dr. Ronald Crystal	15
Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse β^IVS2-654-Thalassemic Erythroid Progenitor Cells	15
Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models	15
Acknowledgment of Reviewers 2021	15
Prediction of Adeno-Associated Virus Fitness with a Protein Language-Based Machine Learning Model	14
Urocortin 2 Gene Transfer for Systolic and Diastolic Dysfunction Due to Chronically Increased Left Ventricular Pressure	14
Genetic Modification of Limbs UsingEx VivoMachine Perfusion	14
Update on Viral Gene Therapy Clinical Trials for Retinal Diseases	14
Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study	13
Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W Strain	13
ESGCTCollaborative Virtual Congress19–22 October 2021Abstracts	13
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles	13
Introduction to ESGCT 2024 Special Issue	13
Development and Delivery of a Hands-On Short Course in Adeno-Associated Virus Manufacturing to Support Growing Workforce Needs in Gene Therapy	12
Onasemnogene Abeparvovec in Type 1 Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis	12
Analysis of HIV-1-Based Lentiviral Vector Particle Composition by PacBio Long-Read Nucleic Acid Sequencing	12

Effects of Urocortin 2 Gene Transfer on Glucose Disposal in Insulin-Resistant db/db Mice on Metformin	12
The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy	12
Progress in Respiratory Gene Therapy	12
Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma	12
Twenty-Year Survival Analysis of Adeno-Associated Virus Vector Serotype 2-Mediated Gene Therapy to the Central Nervous System for CLN2 Disease	12
Transduction of Ferret Surface and Basal Cells of Airways, Lung, Liver, and Pancreas via Intratracheal or Intravenous Delivery of Adeno-Associated Virus 1 or 6	12
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-	12
An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants	12
Correction to: Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W Strain by Jaeil Shin et al. Hum Gene Ther 2021;32:9–10. DOI: 10.1089/hum.2020.050	12
Is Hospital Exemption an Alternative or a Bridge to European Medicines Agency for Developing Academic Chimeric Antigen Receptor T-Cell in Europe? Our Experience with ARI-0001	12
Engineered Human Adenoviruses of Species B and C Report Early, Intermediate Early, and Late Viral Gene Expression	11
Akouos, Immusoft Win FDA Clearances for First-of-Their-Kind Gene Therapies	11
Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond	11
Improving Molecular and Histopathology in Diaphragm Muscle of the Double Transgenic ACTA1-MCM/FLExDUX4 Mouse Model of FSHD with Systemic Antisense Therapy	11
Bluebird Bio Eliminating 30% of Staff in Restructuring	11
Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors	11
Biodistribution of Transplanted Hematopoietic Precursor Cells Injected Through Different Administration Routes in Newborn Mice	11
Production of Recombinant Adeno-Associated Virus Through High-Cell-Density Transfection of HEK293 Cells Based on Fed-Perfusion Culture	11
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article	11
Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination	11
Adeno-Associated Virus Type 9-Mediated Gene Therapy of Choline Acetyltransferase-Deficient Mice	11
Chemical Epigenetic Regulation of Adeno-Associated Virus Delivered Transgenes	11
Efficient Delivery of Adeno-Associated Virus into Inner Ear In Vivo Through Trans-Stapes Route in Adult Guinea Pig	11
Leveraging CRISPR-Cas9 for Accurate Detection of AAV-Neutralizing Antibodies: The AAV-HDR Method	10
A Modified Arrestin1 Increases Lactate Production in the Retina and Slows Retinal Degeneration	10
Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase Deficiency	10
CRISPR-Cas Genome Editing in Ex Vivo Human Lungs to Rewire the Translational Path of Genome-Targeting Therapeutics	10
Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy	10
Pfizer Marks Phase III Success in Hemophilia A, then Layoffs after Failure in DMD	10
Pfizer Weighs Next Steps after DMD Therapy Linked to Boy’s Death Fails Phase III Trial	10
Enhanced Cochlear Transduction by AAV9 with High-Concentration Sucrose	9
Therapeutic Strategy for Fabry Disease by Intravenous Administration of Adeno-Associated Virus 9 in a Symptomatic Mouse Model	9
Liver Gene Therapy	9
A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies	9
Intra-Articular Adeno-Associated Virus-Mediated Proteoglycan 4 Gene Therapy for Preventing Posttraumatic Osteoarthritis	9
Allele-Specific Knockdown of Mutant Huntingtin Protein via Editing at Coding Region Single Nucleotide Polymorphism Heterozygosities	9
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer	9
Preclinical Development of a HIV-Based Gene Therapeutic for Cystic Fibrosis Pulmonary Disease	9
Hemophilia Gene Therapy: The End of the Beginning?	9
Process Development of Recombinant Adeno-Associated Virus Production Platform Results in High Production Yield and Purity	9
Engineering Cancer Selective Virotherapies: Are the Pieces of the Puzzle Falling into Place?	8
Bone Marrow Mesenchymal Stem Cells-Derived Exosomal MicroRNA-150-3p Promotes Osteoblast Proliferation and Differentiation in Osteoporosis	8
Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy	8
Single-Use Capture Purification of Adeno-Associated Viral Gene Transfer Vectors by Membrane-Based Steric Exclusion Chromatography	8
After Sparring with Payers on Pricing, Bluebird Flies Out of Europe	8
Personalizing Oncolytic Virotherapy	8
Modulation of Immune Reaction in Hydrodynamic Gene Therapy for Hemophilia A	8
The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction	8
Association of NPC1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease	8
Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1	8
Adeno-Associated Virus-Mediated Knockdown of Agmatinase Attenuates Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Colorectal Cancer	7
International Conference on Lymphocyte Engineering Author Index	7
Interview with Barry Byrne, MD/PhD	7
Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs	7
Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis	7
Ultragenyx Gene Therapies Spark Lawsuit from Lacks Family	7
Correction to: Letter to the Editor: A Favorable Benefit–Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment, by Qin Hum G	7
Rational Use of Immunosuppressive Corticosteroids in Liver-Directed Adeno-Associated Virus Gene Therapy Studies	7
The Future of Exon Skipping for Duchenne Muscular Dystrophy	7
ESGCT 29th Annual Congress In collaboration with BSGCT Edinburgh, UK October 11–14, 2022 Abstracts	7
Intracisternal AAV9-MAG-hABCD1 Vector Reverses Motor Deficits in Adult Adrenomyeloneuropathy Mice	6
Gene Therapy for Immunoglobulin E, Complement-Mediated, and Eosinophilic Disorders	6
Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges	6
Biodistribution and Tolerability of AAV-PHP.B-CBh-SMN1 in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles	6
A Paradox of the Field's Own Success: Unintended Challenges in Bringing Cutting-Edge Science from the Bench to the Market	6
Development and Application of a Liquid Chromatography-Mass Spectrometry Method for Residual Iodixanol Quantification in AAV-Based Gene Therapy Product Development	6
Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein	6
Genome Editing of Mammalian Cells Through RNA Transcript-Mediated Homologous Recombination Repair	6
AAV-Mediated Gene Transfer of WDR45 Corrects Neurological Deficits in the Mouse Model of Beta-Propeller Protein-Associated Neurodegeneration	6
Adenoviral Transduction ofDickkopf-1Alleviates Silica-Induced Silicosis Development in Lungs of Mice	6
AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys	6
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations	6
HIV Tat-Conjugated Histone H3 Peptides Induce Tumor Cell Death Via Cellular Stress Responses	6
Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats–Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency	6
Blood Cancers Reported in Seven Children Dosed with SKYSONA™	6
Optimized Reversed-Phase Liquid Chromatography/Mass Spectrometry Methods for Intact Protein Analysis and Peptide Mapping of Adeno-Associated Virus Proteins	6
Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67^phox-Deficient Chronic Granulomatous Disease	6
U7 snRNA, a Small RNA with a Big Impact in Gene Therapy	6
Fourth Boy Dies in Clinical Trial of Astellas' AT132	6
Akouos Therapy Restores 11-Year-Old Boy's Hearing After 1 Month	6

Institutional Framework for the Management of Human Genetic Resources in China	6
Interview with Dr. David Williams	5
MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1	5
USP7-SOX9-miR-96-5p-NLRP3 Network Regulates Myocardial Injury and Cardiomyocyte Pyroptosis in Sepsis	5
Optimized Adeno-Associated Virus Vectors for Efficient Transduction of Human Retinal Organoids	5
Acknowledgment of Reviewers 2023	5
Direct Comparison of Epifluorescence and Immunostaining for Assessing Viral Mediated Gene Expression in the Primate Brain	5
Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Human Gene Therapy	5
Remembrances of Kenneth Berns, PhD	5
The Legal Status and Improvement Path of Human Genetic Data in Gene Therapy in China	5
AAV-p40 Bioengineering Platform for Variant Selection Based on Transgene Expression	5
Suicide Gene Delivery System Mediated by Ultrasound-Targeted Microbubble Destruction: A Promising Strategy for Cancer Therapy	5
A Review of the Legislation of Direct-to-Consumer Genetic Testing in China	5
Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A	5
Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer	5
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative PathwayIn Vivo	5
Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective	5
The 2024 Nobel Prize: Impact of the Discovery of miRNA on the Field of Gene Therapy	5
Spanish Society of Gene and Cell Therapy	5
Immune Responses to Muscle-Directed Adeno-Associated Viral Gene Transfer in Clinical Studies	5
Call for Papers: Special Issue on Toxicity And Safety in Clinical AAV Gene Therapy	5
Heart of the Matter: AAV8 Improves Cardiac Function	5
International Conference on Lymphocyte Engineering Author Index	5
Prevalence of Adeno-Associated Virus 3 Capsid Binding and Neutralizing Antibodies in Healthy and Hemophilia B Individuals from India	5
It Is Time to Call Anti-Asian Bias What It Is: Racism	5
Gene Therapy Restores Auditory Functions in an Adult Vglut3 Knockout Mouse Model	5
Efficacy and Safety of a Krabbe Disease Gene Therapy	4
Creating an Innovation Engine to Advance Medicine for Patients with Rare Diseases	4
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice	4
Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes	4
Acknowledgment of Reviewers 2022	4
Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination	4
Concise Analysis of Single-Stranded DNA of Recombinant Adeno-Associated Virus By Automated Electrophoresis System	4
Prevalence of Pre-Existing Neutralizing Antibodies Against Adeno-Associated Virus Serotypes 1, 2, 5, 6, 8, and 9 in Sera of Different Pig Strains	4
Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA Mice	4
Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells	4
Novel Cystic Fibrosis Ferret Model Enables Visualization of CFTR Expression Cells and Genetic CFTR Reactivation	4
Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing	4
Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors	4
Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction	4
Dexamethasone Transiently Enhances Transgene Expression in the Liver When Administered at Late-Phase Post Long-Term Adeno-Associated Virus Transduction	4
Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression	4
Genetic Modification of the AAV5 Capsid with Lysine Residues Results in a Lung-Tropic Liver-Detargeted Gene Transfer Vector	4
Developing Gene Therapy for Mitigating Multisystemic Pathology in Fabry Disease: Proof of Concept in an Aggravated Mouse Model	4
Development of an Inducible, Replication-Competent Assay Cell Line for Titration of Infectious Recombinant Adeno-Associated Virus Vectors	4
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors	4
Remembrances of Nicholas Muzyczka, PhD	4
Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L	4
Update: Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology by Juliette Hordeaux et al. Hum Gene Ther 2020;31:15–16. DOI: 10.1089/hum.2020.167	4
Assessment of Safety and Biodistribution of AAVrh.10hCLN2 Following Intracisternal Administration in Nonhuman Primates for the Treatment of CLN2 Batten Disease	4
International Conference on Lymphocyte Engineering 31 March–2 April 2022 Munich, Germany	3
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy	3
Higher Transduction Efficiency of AAV5 to Neural Stem Cells and Immature Neurons in Gerbil Dentate Gyrus Compared to AAV2 and rh10	3
Cyclosporin H Improves the Transduction of CD34⁺ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease	3
Correction to: Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors, by Westhaus et al. Hum Gene Ther 2023;34(7-8	3
Size Exclusion Chromatography with Dual Wavelength Detection as a Sensitive and Accurate Method for Determining the Empty and Full Capsids of Recombinant Adeno-Associated Viral Vectors	3
Comparison of Physical Perturbation Devices for Enhancing Lentiviral Vector-Mediated Gene Transfer to the Airway Epithelium	3
Interlaboratory Measurement of Adeno-Associated Virus: Comparative Quantification of Full and Empty Capsids	3
Call for Special Issue Papers: Genetic and Nongenetic Inflammation Networks in Major Human Diseases	3
Precision BioSciences, Novartis Launch Up-to-$1.5B In Vivo Genome Editing Collaboration	3
Improvement of Precision in Recombinant Adeno-Associated Virus Infectious Titer Assay with Droplet Digital PCR as an Endpoint Measurement	3
Long-Term Disease Prevention with a Gene Therapy Targeting Oligodendrocytes in a Mouse Model of Adrenomyeloneuropathy	3
Regulatory T Cells and Diabetes Mellitus	3
Interview with Dr. Florian Eichler	3
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates	3
Comprehensive Analysis of Cell Therapy on Chronic Skin Wound Healing: A Meta-Analysis	3
Consequences of Mammalian Target of Rapamycin Inhibition on Adeno-Associated Virus Hepatic Transduction Efficacy	3
The Lived Experience of Pediatric Gene Therapy: A Scoping Review	3
Kallistatin Improves High-Fat-Induced Insulin Resistance via Epididymal Adipose Tissue-Derived Exosomes	3
How Great a Risk Do You Take? A Qualitative Study Exploring Attitudes of Individuals with Friedreich Ataxia Toward Gene Therapy	3
Nonviral Expression of LL-37 in a Human Skin Equivalent to Prevent Infection in Skin Wounds	3
Interview with Beverly Davidson, PhD	3
Neonatal Fc Receptor Inhibition Enables Adeno-Associated Virus Gene Therapy Despite Pre-Existing Humoral Immunity	3
Cure Rare Disease: An Initiative to Enable N of 1 Gene Editing	3
Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A	3
CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma	3
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene Therapy	3
International Conference on Lymphocyte Engineering 12–14 September 2023 Munich, Germany	3
Verve Pauses Enrollment in Base Editing Trial after Adverse Events	3
Preferential Expansion of Human CD34⁺CD133⁺CD90⁺ Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy	3
Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors	3
Restoration of β-Globin Expression with Optimally Designed Lentiviral Vector for β-Thalassemia Treatment in Chinese Patients	3
Food and Drug Administration Sets Stage for Approval of First Duchenne Muscular Dystrophy Gene Therapy	3
Letter to the Editor: A Favorable Benefit–Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment	3
Process Improvements Doom Novartis' Longmont, CO, Plant	3
Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches	3
Finnish Society of Gene and Cell Therapy: A Visionary and Creative Player in the Field	2
Innate Immune Sensing of Adeno-Associated Virus Vectors	2
Beam Results Show First Genetic Correction of Disease-Causing Mutation	2
Bone Marrow Mesenchymal Stem Cell-Mediated Radiosensitive Promoter-Combined Sodium Iodide Symporter for the Treatment of Breast Cancer	2
Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells	2
The RNA World: The Best of Times, the Worst of Times	2
Case Study Cites Immune Reaction to High Adeno-Associated Virus Dose in Explaining Duchenne Muscular Dystrophy Trial Death	2
After Patient Death, FDA Places Hold on Pfizer Duchenne Muscular Dystrophy Gene Therapy Trial	2
Abstract Author Index	2